Eintrag weiter verarbeiten
Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinom...
Gespeichert in:
| Zeitschriftentitel: | Annals of Oncology |
|---|---|
| Personen und Körperschaften: | , , , , , , , |
| In: | Annals of Oncology, 22, 2011, 2, S. 295-300 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Elsevier BV
|
| Schlagwörter: |
| author_facet |
Patil, S. Figlin, R.A. Hutson, T.E. Michaelson, M.D. Négrier, S. Kim, S.T. Huang, X. Motzer, R.J. Patil, S. Figlin, R.A. Hutson, T.E. Michaelson, M.D. Négrier, S. Kim, S.T. Huang, X. Motzer, R.J. |
|---|---|
| author |
Patil, S. Figlin, R.A. Hutson, T.E. Michaelson, M.D. Négrier, S. Kim, S.T. Huang, X. Motzer, R.J. |
| spellingShingle |
Patil, S. Figlin, R.A. Hutson, T.E. Michaelson, M.D. Négrier, S. Kim, S.T. Huang, X. Motzer, R.J. Annals of Oncology Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma Oncology Hematology |
| author_sort |
patil, s. |
| spelling |
Patil, S. Figlin, R.A. Hutson, T.E. Michaelson, M.D. Négrier, S. Kim, S.T. Huang, X. Motzer, R.J. 0923-7534 Elsevier BV Oncology Hematology http://dx.doi.org/10.1093/annonc/mdq342 Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma Annals of Oncology |
| doi_str_mv |
10.1093/annonc/mdq342 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9hbm5vbmMvbWRxMzQy |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9hbm5vbmMvbWRxMzQy |
| institution |
DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Zwi2 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 |
| imprint |
Elsevier BV, 2011 |
| imprint_str_mv |
Elsevier BV, 2011 |
| issn |
0923-7534 |
| issn_str_mv |
0923-7534 |
| language |
English |
| mega_collection |
Elsevier BV (CrossRef) |
| match_str |
patil2011prognosticfactorsforprogressionfreeandoverallsurvivalwithsunitinibtargetedtherapyandwithcytokineasfirstlinetherapyinpatientswithmetastaticrenalcellcarcinoma |
| publishDateSort |
2011 |
| publisher |
Elsevier BV |
| recordtype |
ai |
| record_format |
ai |
| series |
Annals of Oncology |
| source_id |
49 |
| title |
Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma |
| title_unstemmed |
Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma |
| title_full |
Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma |
| title_fullStr |
Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma |
| title_full_unstemmed |
Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma |
| title_short |
Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma |
| title_sort |
prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma |
| topic |
Oncology Hematology |
| url |
http://dx.doi.org/10.1093/annonc/mdq342 |
| publishDate |
2011 |
| physical |
295-300 |
| description |
|
| container_issue |
2 |
| container_start_page |
295 |
| container_title |
Annals of Oncology |
| container_volume |
22 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792335798111043589 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T14:50:16.458Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Prognostic+factors+for+progression-free+and+overall+survival+with+sunitinib+targeted+therapy+and+with+cytokine+as+first-line+therapy+in+patients+with+metastatic+renal+cell+carcinoma&rft.date=2011-02-01&genre=article&issn=0923-7534&volume=22&issue=2&spage=295&epage=300&pages=295-300&jtitle=Annals+of+Oncology&atitle=Prognostic+factors+for+progression-free+and+overall+survival+with+sunitinib+targeted+therapy+and+with+cytokine+as+first-line+therapy+in+patients+with+metastatic+renal+cell+carcinoma&aulast=Motzer&aufirst=R.J.&rft_id=info%3Adoi%2F10.1093%2Fannonc%2Fmdq342&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792335798111043589 |
| author | Patil, S., Figlin, R.A., Hutson, T.E., Michaelson, M.D., Négrier, S., Kim, S.T., Huang, X., Motzer, R.J. |
| author_facet | Patil, S., Figlin, R.A., Hutson, T.E., Michaelson, M.D., Négrier, S., Kim, S.T., Huang, X., Motzer, R.J., Patil, S., Figlin, R.A., Hutson, T.E., Michaelson, M.D., Négrier, S., Kim, S.T., Huang, X., Motzer, R.J. |
| author_sort | patil, s. |
| container_issue | 2 |
| container_start_page | 295 |
| container_title | Annals of Oncology |
| container_volume | 22 |
| description | |
| doi_str_mv | 10.1093/annonc/mdq342 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9hbm5vbmMvbWRxMzQy |
| imprint | Elsevier BV, 2011 |
| imprint_str_mv | Elsevier BV, 2011 |
| institution | DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229 |
| issn | 0923-7534 |
| issn_str_mv | 0923-7534 |
| language | English |
| last_indexed | 2024-03-01T14:50:16.458Z |
| match_str | patil2011prognosticfactorsforprogressionfreeandoverallsurvivalwithsunitinibtargetedtherapyandwithcytokineasfirstlinetherapyinpatientswithmetastaticrenalcellcarcinoma |
| mega_collection | Elsevier BV (CrossRef) |
| physical | 295-300 |
| publishDate | 2011 |
| publishDateSort | 2011 |
| publisher | Elsevier BV |
| record_format | ai |
| recordtype | ai |
| series | Annals of Oncology |
| source_id | 49 |
| spelling | Patil, S. Figlin, R.A. Hutson, T.E. Michaelson, M.D. Négrier, S. Kim, S.T. Huang, X. Motzer, R.J. 0923-7534 Elsevier BV Oncology Hematology http://dx.doi.org/10.1093/annonc/mdq342 Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma Annals of Oncology |
| spellingShingle | Patil, S., Figlin, R.A., Hutson, T.E., Michaelson, M.D., Négrier, S., Kim, S.T., Huang, X., Motzer, R.J., Annals of Oncology, Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma, Oncology, Hematology |
| title | Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma |
| title_full | Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma |
| title_fullStr | Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma |
| title_full_unstemmed | Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma |
| title_short | Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma |
| title_sort | prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma |
| title_unstemmed | Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma |
| topic | Oncology, Hematology |
| url | http://dx.doi.org/10.1093/annonc/mdq342 |